Cargando…

The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study

BACKGROUND: Osteoporosis affects quality of life (QoL) and may lead to depression in women. The purpose of this study was to evaluate the effects of zoledronic acid (ZA) treatment on depression and QoL in women with postmenopausal osteoporosis (PO). MATERIALS AND METHODS: A total of 88 newly diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gokosmanoglu, Feyzi, Varim, Ceyhun, Atmaca, Aysegul, Atmaca, Mehmet Hulusi, Colak, Ramis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331768/ https://www.ncbi.nlm.nih.gov/pubmed/28255320 http://dx.doi.org/10.4103/1735-1995.193503

Ejemplares similares

Marine-Lenhart syndrome with papillary thyroid carcinoma
por: Atmaca, Hulusi, et al.
Publicado: (2015)

Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)

The lateralization accuracy of inferior petrosal sinus sampling in Cushing’s disease: experiences of a tertiary center
por: DURMUŞ, Elif Tutku, et al.
Publicado: (2022)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
por: Lin, Haiqing, et al.
Publicado: (2021)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
por: Gazoni, Fernanda Martins, et al.
Publicado: (2023)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis
por: Pyone, Zar Chi, et al.
Publicado: (2020)

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis
por: Host, L.V., et al.
Publicado: (2022)

Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid
por: Carmona, Raj, et al.
Publicado: (2009)

Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis
por: Nakamura, Yumejiro, et al.
Publicado: (2021)

Depression, Quality of Life, and Self-Esteem of Moroccan Postmenopausal Women with Osteoporosis before the Occurrence of Fractures
por: Bahouq, Hanane, et al.
Publicado: (2020)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Bellone, Federica, et al.
Publicado: (2021)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
por: Spangler, Leslie, et al.
Publicado: (2023)

Effect of Zoledronic Acid on the Vertebral Body Bone Mineral Density After Instrumented Intervertebral Fusion in Postmenopausal Women With Osteoporosis
por: Fan, Junjun, et al.
Publicado: (2021)

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
por: Golmohamdi, Fateme Rostami, et al.
Publicado: (2016)

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2022)

Quality of Life, Anxiety and Depression in Turkish Women Prior to Receiving Assisted Reproductive Techniques
por: Pinar, Gul, et al.
Publicado: (2012)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Uehara, Masashi, et al.
Publicado: (2021)

Clinical assessment of patients with acromegaly
por: Gokosmanoglu, Feyzi, et al.
Publicado: (2018)

Influence of Flexible Insulin Dosing with Carbohydrate Counting Method on Metabolic and Clinical Parameters in Type 1 Diabetes Patients
por: Gokosmanoglu, Feyzi, et al.
Publicado: (2018)

Psychological state, quality of life, and body composition in postmenopausal women with osteoporosis in Lithuania
por: Lasaite, Lina, et al.
Publicado: (2009)

Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures
por: Ciubean, Alina Deniza, et al.
Publicado: (2018)

The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
por: Khajuria, Deepak Kumar, et al.
Publicado: (2014)

Experimental model of osteoporosis: comparison between ovariectomy and botulinum toxin a
por: Atmaca, Halil, et al.
Publicado: (2013)

Nuclear morphometric and morphological analysis of exfoliated buccal and tongue dorsum cells in type-1 diabetic patients
por: Oz, Zehra Safi, et al.
Publicado: (2014)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
por: Lambrinoudaki, Irene, et al.
Publicado: (2008)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

Effects of 12-months treatment with zoledronate or teriparatide on intima-media thickness of carotid artery in women with postmenopausal osteoporosis: A pilot study
por: Passeri, Elena, et al.
Publicado: (2019)

Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2020)

Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study
por: Ljunggren, Östen, et al.
Publicado: (2013)

The relationship between Vitamin D deficiency and polycystic ovary syndrome
por: Gokosmanoglu, Feyzi, et al.
Publicado: (2020)

Association of the Bioimpedance Phase Angle and Quality of Life in Postmenopausal Osteoporosis
por: Ono, Yuichi, et al.
Publicado: (2022)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Piper, Paul K, et al.
Publicado: (2009)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uurieq375prbva01jg7fsd9rdo